Search

everythinglearnresearchcommunity

for

Search:↓

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

The link between pemphigus and the patient's scarring hair loss is still unclear.

CCCA can affect both genders and all ages, and it has a genetic component.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

A 12-year-old boy's hair loss and skin issues improved significantly with medication.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Effective hair loss treatment requires personalized approaches and patient-provider collaboration.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.